While at Arista, Duff led all aspects of the business with full P&L responsibility, and initiated significant cultural organization changes to drive improved performance and growth based on customer-driven strategic plans and value propositions across new markets and regions.

The deal provides for Innophos Nutrition to sell, market and distribute Theravalues’ Theracurmin® and EMIQ® products.

Mr. Gress will continue to serve as Chairman during a transition period, expected to last approximately three months. After the transition period, the Company said Mr. Gress will step down as Chairman and director, and it expects Dr. Mink will be appointed to the Board of Directors.

Our focus is on research and development of innovative new products and customer-tailored solutions designed to meet the ever-changing landscape of global regulations and consumer demands.

Innophos offers Smart-Salt low sodium salt substitutes to reduce sodium levels in baked goods, meat, seafood, poultry, dairy and beverages.

Innophos Holdings Inc. entered into a binding agreement and completed the acquisition of Kelatron Corporation.

Innophos Holdings Inc. announced its financial results for the first quarter 2011.